Selected article for: "disease form and severe pneumonia"
Author: Scialo, Filippo; Daniele, Aurora; Amato, Felice; Pastore, Lucio; Matera, Maria Gabriella; Cazzola, Mario; Castaldo, Giuseppe; Bianco, Andrea
Title: ACE2: The Major Cell Entry Receptor for SARS-CoV-2
  • Cord-id: ciamusjs
  • Document date: 2020_11_10
    • ID: ciamusjs
    Snippet: Despite the unprecedented effort of the scientific community, the novel SARS-CoV-2 virus has infected more than 46 million people worldwide, killing over one million two hundred thousand. Understanding the mechanisms by which some individuals are more susceptible to SARS-CoV-2 infection and why a subgroup of them are prone to experience severe pneumonia, and death should lead to a better approach and more effective treatments for COVID-19. Here, we focus our attention on ACE2, a primary receptor
    Document: Despite the unprecedented effort of the scientific community, the novel SARS-CoV-2 virus has infected more than 46 million people worldwide, killing over one million two hundred thousand. Understanding the mechanisms by which some individuals are more susceptible to SARS-CoV-2 infection and why a subgroup of them are prone to experience severe pneumonia, and death should lead to a better approach and more effective treatments for COVID-19. Here, we focus our attention on ACE2, a primary receptor of SARS-CoV-2. We will discuss its biology, tissue expression, and post-translational regulation that determine its potential to be employed by SARS-CoV-2 for cell entry. Particular attention will be given to how the ACE2 soluble form can have a great impact on disease progression and thus be used in a potential therapeutic strategy. Furthermore, we will discuss repercussions that SARS-CoV-2/ACE2 binding has on the renin–angiotensin system and beyond. Indeed, although mostly neglected, ACE2 can also act on [des-Arg 937]-bradykinin of the kinin–kallikrein system regulating coagulation and inflammation. Thorough comprehension of the role that ACE2 plays in different pathways will be the key to assess the impact that SARS-CoV-2/ACE2 binding has on organismal physiology and will help us to find better therapies and diagnostic tools.

    Search related documents:
    Co phrase search for related documents
    • ace receptor and action exert: 1
    • ace receptor and active peptide: 1, 2
    • ace receptor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace receptor and local increase: 1
    • ace receptor and low affinity: 1
    • acei enzyme inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5
    • action exert and acute respiratory syndrome: 1, 2
    • active peptide and acute respiratory syndrome: 1, 2, 3, 4
    • acute respiratory syndrome and adaptive mutation: 1, 2, 3, 4, 5
    • acute respiratory syndrome and adenine dinucleotide phosphate nadph: 1
    • acute respiratory syndrome and local increase: 1, 2, 3, 4, 5
    • acute respiratory syndrome and local vascular leakage: 1, 2
    • acute respiratory syndrome and local vascular leakage prone: 1
    • acute respiratory syndrome and local vascular leakage prone lung environment: 1
    • acute respiratory syndrome and low affinity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15